A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal
Phase 2
- Conditions
- squamous cell carcinoma of the anal canal
- Registration Number
- JPRN-UMIN000012184
- Lead Sponsor
- Japanese Radiation Oncology Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Other active cancer 2) Severe active co-morbidity such as severe heart disease, uncontrolled DM, and severe infection 3) Women who are or would be pregnant or who are lactating 4) Anti-HIV Ab positive 5) HBs Ag positive 6) Patient who the physician in charge judged unsuitable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2-year disease-free survival
- Secondary Outcome Measures
Name Time Method